CorMedix (CRMD) Operating Expenses (2010 - 2025)

CorMedix has disclosed Operating Expenses across 15 years of filings, most recently posting $48.2 million for Q4 2025.

• Operating Expenses for Q4 2025 came in at $48.2 million, up 181.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $125.6 million (up 100.53% YoY), and the FY2025 annual result was $125.6 million, up 100.53% from the prior year.
• Operating Expenses came in at $48.2 million for Q4 2025 at CorMedix, up from $41.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $48.2 million in Q4 2025 to a low of $5.9 million in Q2 2021.
• The 5-year median for Operating Expenses is $11.4 million (2023), against an average of $14.9 million.
• Across the five-year window, Operating Expenses plunged 34.11% in 2021 and surged 196.9% in 2025, its largest moves.
• CorMedix's Operating Expenses stood at $7.8 million in 2021, then rose by 8.09% to $8.4 million in 2022, then jumped by 86.12% to $15.7 million in 2023, then gained by 9.12% to $17.1 million in 2024, then soared by 181.79% to $48.2 million in 2025.
• The last three Operating Expenses figures came in at $48.2 million (Q4 2025), $41.7 million (Q3 2025), and $18.3 million (Q2 2025), per Business Quant data.